HomeNIRVF • OTCMKTS
add
Nirvana Life Sciences Inc
Previous close
$0.076
Year range
$0.080 - $0.080
Market cap
24.12K CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 47.90K | -23.39% |
Net income | -53.24K | 32.38% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.35K | 111.13% |
Total assets | 20.32K | -0.59% |
Total liabilities | 729.54K | -46.17% |
Total equity | -709.22K | — |
Shares outstanding | 22.92M | — |
Price to book | -2.54 | — |
Return on assets | -585.84% | — |
Return on capital | 22.94% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Net income | -53.24K | 32.38% |
Cash from operations | -4.39K | 97.58% |
Cash from investing | — | — |
Cash from financing | 6.24K | -85.46% |
Net change in cash | -509.00 | 92.72% |
Free cash flow | 13.75K | 763.24% |
About
Founded
2011
Headquarters
Website
Employees
2
